期刊
BIOMEDICINES
卷 11, 期 1, 页码 -出版社
MDPI
DOI: 10.3390/biomedicines11010058
关键词
long non-coding RNA; GAS5; competing endogenous RNA; BAX; microRNA
This study found that long non-coding RNA (lncRNA) GAS5 is downregulated in colon cancer cell lines resistant to 5-fluorouracil (5-FU). GAS5 downregulation decreased the viability of HCT116 cells and the level of the pro-apoptotic protein BAX, while GAS5 overexpression promoted cell death in response to 5-FU. GAS5 promoted cell death by interfering with miR-128-3p-mediated BAX downregulation, suggesting that GAS5 overexpression in chemo-resistant cancer cells may improve the efficacy of anti-cancer drugs.
The acquisition of drug resistance is a major hurdle for effective cancer treatment. Although several efforts have been made to overcome drug resistance, the underlying mechanisms have not been fully elucidated. This study investigated the role of long non-coding RNA (lncRNA) growth arrest-specific 5 (GAS5) in drug resistance. GAS5 was found to be downregulated in colon cancer cell lines that are resistant to 5-fluorouracil (5-FU). Downregulation of GAS5 decreased the viability of HCT116 cells and the level of the pro-apoptotic BAX protein, while GAS5 overexpression promoted cell death in response to 5-FU. The interaction between GAS5 and BAX mRNA was investigated using MS2-tagged RNA affinity purification (MS2-trap) followed by RT-qPCR, and the results showed that GAS5 bound to the 3 '-untranslated region of BAX mRNA and enhanced its expression by interfering with the inhibitory effect of microRNA-128-3p, a negative regulator of BAX. In addition, ectopic expression of GAS5 increased the sensitivity of resistant cells in response to anti-cancer drugs. These results suggest that GAS5 promoted cell death by interfering with miR-128-3p-mediated BAX downregulation. Therefore, GAS5 overexpression in chemo-resistant cancer cells may be a potential strategy to improve the anti-cancer efficacy of drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据